Neuphoria Therapeutics Inc.
	Q4-CY2025	Q3-CY2025	Q2-CY2025	Q1-CY2025	Q4-CY2024	Q3-CY2024	Q2-CY2024	Q1-CY2024	Q4-CY2023	Q3-CY2023	Q2-CY2023	Q1-CY2023	Q4-CY2022	Q3-CY2022	Q2-CY2022	Q1-CY2022	Q4-CY2021	Q3-CY2021	Q2-CY2021	Q1-CY2021	Q4-CY2020	Q3-CY2020	Q2-CY2020	Q1-CY2020	Q4-CY2019	Q3-CY2019	Q2-CY2019	Q1-CY2019	Q4-CY2018	Q3-CY2018	Q2-CY2018	Q1-CY2018	Q4-CY2017	Q3-CY2017	Q2-CY2017	Q1-CY2017	Q4-CY2016	Q3-CY2016	Q2-CY2016	Q1-CY2016	Q4-CY2015	Q3-CY2015	Q2-CY2015	Q1-CY2015	Q4-CY2014	Q3-CY2014	Q2-CY2014	Q1-CY2014	Q4-CY2013
Balance Sheet Date			2025-Jun-30	2025-Mar-31	2024-Dec-31	2024-Sep-30	2024-Jun-30
Fiscal Period			Q4-FY2025	Q3-FY2025	Q2-FY2025	Q1-FY2025	Q4-FY2024
Total Assets			28,589,614$	30,713,319$	18,168,220$	22,917,207$	27,649,093$				28,562,948$
Total Current Assets			15,040,831$	17,090,239$	4,398,608$	8,429,478$	13,193,758$				13,326,612$
Cash and Cash Equivalents			14,210,745$	17,044,750$	4,344,578$	8,082,410$	12,608,109$	8,426,061$	10,154,961$	8,135,059$	12,103,047$
Receivables
Other Current Assets
Assets Held for Sale in Short Term
Total Noncurrent Assets			13,548,783$	13,623,080$	13,769,612$	14,487,729$	14,455,335$				15,236,336$
Goodwill			8,638,609$	8,451,038$	8,407,271$	8,903,988$	8,690,018$	8,626,104$	8,840,075$	8,574,696$	8,694,186$
Other Intangible Assets			4,804,791$	4,970,474$	5,136,157$	5,301,839$	5,467,522$				6,130,253$
Physical Assets			2,771$	1,623$	1,683$	1,964$	1,994$				2,522$
Other Noncurrent Assets
Assets Held for Sale in Long Term
Total Liabilities			9,587,040$	4,716,011$	4,420,225$	5,846,843$	10,158,721$				6,552,385$
Total Current Liabilities			4,220,760$	1,552,063$	2,133,674$	2,551,713$	3,829,073$				2,738,788$
Accounts Payable			1,154,369$	745,336$	1,530,667$	1,325,994$	2,243,662$				1,439,291$
Short Term Debt
Short Term Capital Lease Obligations			116,314$	121,738$	118,492$	129,881$	121,990$				113,930$
Other Current Liabilities			35,756$	32,994$	31,600$	33,306$	37,581$				39,405$
Total Noncurrent Liabilities			5,366,280$	3,163,948$	2,286,551$	3,295,130$	6,329,648$				3,813,597$
Long Term Debt
Long Term Capital Lease Obligations				19,322$	49,818$	89,469$	117,628$				239,835$
Other Noncurrent Liabilities				3,647$	3,389$	3,437$	2,886$				14,850$
Total Equity			19,002,574$	25,997,308$	13,747,995$	17,070,364$	17,490,372$	17,945,737$	19,497,443$	17,227,512$	22,010,563$
Equity to Minority
Equity to Common Shareholders			19,002,574$	25,997,308$	13,747,995$	17,070,364$	17,490,372$	17,945,737$	19,497,443$	17,227,512$	22,010,563$
Additional Paid-In Capital			200,194,324$	199,372,800$	198,189,833$	198,280,436$	198,481,027$				187,554,251$
Retained Earnings			(178,346,703$)	(169,463,046$)	(180,725,207$)	(178,781,858$)	(177,977,071$)				(162,484,905$)
Treasury Stock
Capital Lease Obligations			116,314$	141,060$	168,310$	219,350$	239,618$				353,765$

• Income Statement
• Balance Sheet
• Cash Flow
• Ratios
• Market Data
• Valuation